See more : Gulf Navigation Holding PJSC (GULFNAV.AE) Income Statement Analysis – Financial Results
Complete financial analysis of RPG Life Sciences Limited (RPGLIFE.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of RPG Life Sciences Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Yuma Energy, Inc. (YUMAQ) Income Statement Analysis – Financial Results
- Stallion Gold Corp. (SLLGF) Income Statement Analysis – Financial Results
- Burberry Group plc (BBRYF) Income Statement Analysis – Financial Results
- Univar Solutions Inc. (UNVR) Income Statement Analysis – Financial Results
- Ajax I (AJAX) Income Statement Analysis – Financial Results
RPG Life Sciences Limited (RPGLIFE.BO)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.rpglifesciences.com
About RPG Life Sciences Limited
RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, anti-spasmodic, etc. It provides generics primarily in area of immunosuppressant therapy; and finished dosage formulations for various therapies. It operates in nephrology, rheumatology, oncology, gastroenterology, cardiovascular, orthopedics, respiratory, neurology, general, urology, anti-diabetic, anti-dengue, vitamins and minerals, gynecology, pediatrics, etc. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008. RPG Life Sciences Limited was founded in 1968 and is headquartered in Mumbai, India. RPG Life Sciences Limited is a subsidiary of Nucleus Life Trust.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 5.82B | 5.09B | 4.37B | 3.83B | 3.69B | 3.24B | 3.37B | 2.88B | 2.79B | 2.42B | 2.36B | 2.22B | 1.93B | 1.87B | 1.60B | 1.40B | 1.28B | 1.20B |
| Cost of Revenue | 1.94B | 1.78B | 1.50B | 1.38B | 1.35B | 1.10B | 1.15B | 1.03B | 914.40M | 846.90M | 767.50M | 764.40M | 552.90M | 497.20M | 465.24M | 422.57M | 391.80M | 419.31M |
| Gross Profit | 3.88B | 3.31B | 2.87B | 2.46B | 2.34B | 2.14B | 2.23B | 1.85B | 1.87B | 1.57B | 1.59B | 1.45B | 1.38B | 1.37B | 1.13B | 982.16M | 885.41M | 783.54M |
| Gross Profit Ratio | 66.64% | 64.99% | 65.64% | 64.10% | 63.52% | 66.03% | 66.01% | 64.36% | 67.22% | 64.98% | 67.42% | 65.51% | 71.33% | 73.39% | 70.89% | 69.92% | 69.32% | 65.14% |
| Research & Development | 0.00 | 72.20M | 72.20M | 69.20M | 76.06M | 75.00M | 800.00K | 3.30M | 12.20M | 102.50M | 75.50M | 73.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 1.33B | 181.70M | 196.60M | 151.70M | 128.40M | 95.00M | 80.30M | 72.10M | 47.60M | 52.10M | 51.60M | 47.10M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 213.00M | 356.20M | 322.70M | 254.70M | 201.30M | 186.10M | 224.30M | 179.00M | 165.10M | 114.20M | 121.90M | 120.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 1.54B | 537.90M | 519.30M | 406.40M | 329.70M | 281.10M | 304.60M | 251.10M | 212.70M | 166.30M | 992.60M | 842.70M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | 600.00K | 29.90M | 1.00M | 7.30M | 3.70M | -25.60M | -31.40M | -81.60M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 1.64B | 2.42B | 2.15B | 1.91B | 1.90B | 1.95B | 1.96B | 1.67B | 1.73B | 1.52B | 1.58B | 1.38B | 1.29B | 1.13B | 906.33M | 812.90M | 707.15M | 568.45M |
| Cost & Expenses | 3.53B | 4.20B | 3.65B | 3.29B | 3.25B | 3.05B | 3.11B | 2.70B | 2.64B | 2.37B | 2.34B | 2.15B | 1.84B | 1.63B | 1.37B | 1.24B | 1.10B | 987.76M |
| Interest Income | 14.20M | 27.30M | 13.30M | 3.20M | 1.70M | 1.20M | 100.00K | 4.00M | 300.00K | 1.60M | 1.10M | 800.00K | 200.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 14.40M | 3.10M | 5.20M | 7.90M | 17.50M | 39.90M | 38.00M | 25.30M | 24.60M | 27.20M | 25.60M | 74.40M | 68.80M | 62.80M | 81.39M | 86.12M | 85.25M | 115.69M |
| Depreciation & Amortization | 170.70M | 155.00M | 156.60M | 164.70M | 163.60M | 153.20M | 143.40M | 113.10M | 101.50M | 113.60M | 106.10M | 98.70M | 102.20M | 95.20M | 91.82M | 94.18M | 77.59M | 49.37M |
| EBITDA | 1.36B | 1.08B | 902.40M | 718.40M | 555.70M | 352.30M | 394.20M | 294.90M | 242.30M | 141.70M | 155.00M | 205.00M | 188.20M | 332.70M | 318.73M | 263.43M | 255.84M | 264.47M |
| EBITDA Ratio | 23.43% | 20.98% | 20.26% | 18.52% | 16.32% | 10.63% | 11.80% | 10.06% | 9.04% | 7.15% | 5.94% | 7.66% | 9.76% | 17.81% | 19.94% | 18.75% | 20.03% | 21.99% |
| Operating Income | 2.29B | 874.70M | 705.20M | 497.30M | 385.40M | 144.60M | 183.60M | 127.00M | 66.90M | 59.40M | 33.90M | 71.10M | 86.00M | 237.50M | 226.91M | 169.25M | 178.25M | 215.10M |
| Operating Income Ratio | 39.38% | 17.18% | 16.13% | 12.97% | 10.44% | 4.46% | 5.45% | 4.41% | 2.40% | 2.46% | 1.44% | 3.21% | 4.46% | 12.71% | 14.20% | 12.05% | 13.96% | 17.88% |
| Total Other Income/Expenses | -1.11B | -1.02B | -958.10M | -856.20M | -77.70M | -41.40M | -58.20M | -34.30M | -28.90M | -42.40M | 637.30M | -100.90M | -68.60M | -62.80M | -81.39M | -86.12M | -85.25M | -115.69M |
| Income Before Tax | 1.18B | 916.80M | 731.70M | 535.80M | 364.50M | 150.50M | 203.60M | 145.40M | 116.20M | 10.00M | 649.70M | 5.40M | 17.40M | 174.70M | 145.51M | 83.14M | 93.01M | 99.41M |
| Income Before Tax Ratio | 20.25% | 18.01% | 16.74% | 13.98% | 9.87% | 4.65% | 6.04% | 5.05% | 4.17% | 0.41% | 27.58% | 0.24% | 0.90% | 9.35% | 9.10% | 5.92% | 7.28% | 8.26% |
| Income Tax Expense | 301.80M | 240.40M | 216.90M | 135.80M | 74.40M | 42.40M | 69.10M | 24.50M | 51.20M | 0.00 | 115.70M | -38.70M | 8.90M | 47.60M | 37.55M | 17.06M | 33.47M | 16.75M |
| Net Income | 876.60M | 676.40M | 514.80M | 400.00M | 290.10M | 108.10M | 134.50M | 210.10M | 116.20M | 10.00M | 534.00M | 44.10M | 8.50M | 127.10M | 107.96M | 66.08M | 59.54M | 80.38M |
| Net Income Ratio | 15.06% | 13.29% | 11.78% | 10.43% | 7.86% | 3.34% | 3.99% | 7.30% | 4.17% | 0.41% | 22.67% | 1.99% | 0.44% | 6.80% | 6.75% | 4.70% | 4.66% | 6.68% |
| EPS | 53.00 | 40.90 | 31.13 | 24.19 | 17.54 | 6.54 | 8.13 | 12.70 | 7.03 | 0.60 | 32.29 | 2.67 | 0.51 | 7.69 | 7.51 | 4.60 | 4.19 | 5.59 |
| EPS Diluted | 53.00 | 40.90 | 31.13 | 24.19 | 17.54 | 6.54 | 8.13 | 12.70 | 7.03 | 0.60 | 32.29 | 2.67 | 0.51 | 7.69 | 6.54 | 4.59 | 4.19 | 5.59 |
| Weighted Avg Shares Out | 16.54M | 16.54M | 16.54M | 16.54M | 16.54M | 16.54M | 16.54M | 16.54M | 16.54M | 16.54M | 16.54M | 16.54M | 16.54M | 16.54M | 14.37M | 14.37M | 14.21M | 14.37M |
| Weighted Avg Shares Out (Dil) | 16.54M | 16.54M | 16.54M | 16.54M | 16.54M | 16.54M | 16.54M | 16.54M | 16.54M | 16.54M | 16.54M | 16.54M | 16.54M | 16.54M | 16.51M | 14.38M | 14.21M | 14.37M |
Source: https://incomestatements.info
Category: Stock Reports